3.8 Review

HDAC6: Physiological function and its selective inhibitors for cancer treatment

期刊

DRUG DISCOVERIES AND THERAPEUTICS
卷 7, 期 6, 页码 233-242

出版社

INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
DOI: 10.5582/ddt.2013.v7.6.233

关键词

Histone deacetylases; HDAC6; cancer; inhibitor

资金

  1. national high technology research and development program of China (863 project) [2007AA02Z314]
  2. National Science and Technology Major Project [2009ZX09103-118]

向作者/读者索取更多资源

Acetylation and deacetylation of histones are important in regulating gene expression and play a key role in modification of gene transcription. Specific HDACs isoforms can be regarded as a target for cancer therapy avoiding side-effects, HDAC6 with a unique physiological function and structure has become a hot issue recently. The unique isoform HDAC6 is involved in tumorigenesis, development and metastasis through tubulin, HSP90, invasin and ubiquitin-protein. Here we review the structure elements, biological function, and recent selective inhibitors of HDAC6, and study the structure-activity and structure-selectivity relationship.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据